PTGX
PTGX
NASDAQ · Biotechnology

Protagonist Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$99.36
+0.51 (+0.52%)
As of May 9, 1:17 AM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 17 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target -69.3% upside
Low Target $24.78
Average Target $30.47
High Target $49.57
Current Price $99.36
Current
$99.36
Target
$30.47
$24.78 $30.47 avg $49.57
Scenario Analysis
Bear Case
$24.78
-75.1%
Low target
Base Case
$30.47
-69.3%
Avg target
Bull Case
$49.57
+-50.1%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$107.84
-7.9% from high
52-Week Low
$41.29
+140.7% from low
50-Day SMA
$85.10
+16.8% vs SMA
200-Day SMA
$67.75
+46.7% vs SMA
RSI (14)
58.3
Neutral
Target vs 52W High
$30.47
-71.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%